Egypt Contact Lenses Market was valued at $47.99 Mn in 2023 and is predicted to grow at a CAGR of 10.4% from 2023 to 2030, $95.93 Mn by 2030. The key drivers of this industry include the rising vision problems, growing disposable income, and technological advancement. The industry is primarily dominated by Bausch and Lomb, CooperVision, Alcon Vision, and Essilor among others.
Egypt Contact Lenses Market was valued at $47.99 Mn in 2023 and is predicted to grow at a CAGR of 10.4% from 2023 to 2030, $95.93 Mn by 2030.
Contact lenses are versatile medical devices placed directly on the eye, serving both functional and cosmetic purposes. They come in several types: soft lenses, made of flexible plastic allowing oxygen to the cornea; rigid gas permeable lenses for sharper vision; hybrid lenses combining features of both; and scleral lenses covering the cornea and sclera, useful for irregular corneas. They correct refractive errors like myopia and hyperopia and cater to cosmetic needs with colored variants. Fitting by an optometrist or ophthalmologist ensures proper selection based on individual eye health and lifestyle. Regular cleaning and adherence to wearing schedules are crucial for preventing infections and maintaining eye health. Risks include infections, dry eyes, and corneal abrasions if not used correctly. Regulated as medical devices, advancements like silicone hydrogel materials and UV-blocking capabilities enhance safety and comfort, making contact lenses a popular choice for vision correction and aesthetic enhancement globally.
Globally, eye health is a critical concern, with at least 2.2 Bn people experiencing vision impairment or blindness, of which 1 Bn cases could have been prevented or remain unaddressed due to factors like aging populations, lifestyle changes, and limited access to eye care in low- and middle-income countries. Approximately 224 Mn people worldwide are highly nearsighted, and 36.1% of the U.S. population has myopia, particularly in urban areas. Eye injuries from foreign bodies, explosive injuries, road accidents, and self-inflicted harm present additional challenges. Addressing visual impairments caused by refractive errors, cataracts, macular degeneration, glaucoma, and diabetic retinopathy requires an estimated $14.3 Bn
The market therefore is driven by significant factors like rising vision problems, growing disposable income, and technological advancements. However cost, limited eye care awareness, regulations and distribution restrict the growth and potential of the market.
Prominent players in this field are Bausch and Lomb, which emphasizes daily disposable contact lenses enhanced with comfort technologies and supports sustainability initiatives. On the other hand, CooperVision focuses on innovation through advanced materials, specialized solutions for myopia management, and convenient subscription services for contact lenses. Other contributors include Alcon Vision LLC, and Essilor International S.A. among others.
Market Growth Drivers
Rising Vision Problems: High prevalence of myopia (near-sightedness) in Egypt, particularly among young adults. A survey suggests the prevalence could be as high as 30-40% among university students. This increasing need for vision correction fuels the demand for contact lenses.
Growing Disposable Income: Egypt's economy is experiencing growth, leading to rising disposable incomes. This allows more people to afford contact lenses, which were previously considered a luxury item for many.
Technological Advancements: New materials and technologies like silicone hydrogel and daily disposable lenses are readily available in France. These advancements offer improved comfort, wearability, and user experience, encouraging more people to choose contact lenses.
Market Restraints
Cost: Contact lenses can still be costly, particularly specialty lenses or those needing frequent replacement. This can pose a challenge for some consumers, although the market for more affordable private-label lenses is expanding.
Limited Eye Care Awareness: Improper contact lens use can lead to eye infections and other complications. Raising awareness about proper lens care and hygiene practices is crucial. Studies suggest a knowledge gap exists regarding proper hygiene practices.
The Egyptian contact lens market is regulated by the Egyptian Drug Authority (EDA) and the Ministry of Health and Population (MOHP). The EDA is responsible for registering and regulating all medical devices, including contact lenses. Manufacturers must submit technical documentation and samples for testing and approval before selling lenses in Egypt. The MOHP ensures the safety and quality of these devices by establishing regulations and guidelines for labeling, advertising, and distribution. Key regulatory considerations include the mandatory registration of all contact lenses with the EDA, labeling requirements in Arabic that must include detailed product information, and truthful advertising that necessitates specific approval for therapeutic claims. Distribution is restricted to licensed pharmacies, optical shops, and ophthalmologists who can dispense lenses to their patients.
In Egypt, contact lenses are generally not covered by health insurance, requiring patients to pay out-of-pocket. This is largely because contact lenses are classified as non-essential medical devices compared to corrective glasses. Public health insurance plans in Egypt typically focus on essential medical services and medications, prioritizing preventative care and the treatment of chronic illnesses. This focus limits the coverage for non-essential items like contact lenses, thereby influencing the reimbursement landscape and making patients responsible for the full cost of their contact lenses.
Key Players
Here are some of the major key players in the Egypt Contact Lenses Market
1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Material
By Design
By Application
By Distribution Channel
By Usage
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.